Literature DB >> 25318894

Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis.

Yan Tan1,2, Kai-Fang Zou3, Wei Qian1, Sheng Chen1, Xiao-Hua Hou1.   

Abstract

Toll-like receptors (TLRs) family may play important roles in inflammatory bowel disease. This study examined the expression of TLR2, TLR4 and TLR9 in the colonic tissues of patients with ulcerative colitis (UC) and explored their roles in the pathogenesis of UC. Colonic biopsies were taken from the colon of 30 patients with mild or moderate UC (at active phase) and 10 healthy controls during colonoscopy. TLR2, TLR4 and TLR9 protein expression levels were immunohistochemically detected. The mRNA expression levels of TLR2, TLR4 and TLR9 were assessed by reverse transcription polymerase chain reaction (RT-PCR). The disease activity index (DAI), colonoscopic and histologic grades and fecal microbial flora were determined. Histological examination showed that the intestinal mucous membrane of UC patients underwent acute inflammation changes. Immunohistochemistry exhibited that the expression levels of TLR2, TLR4 and TLR9 in colon epithelia and inflammatory cells were higher in UC patients than in control group (P<0.01). The mRNA expression levels of TLR2, TLR4 and TLR9 were increased in UC patients but were not detected in the normal controls. Expression levels of TLR2, TLR4 and TLR9 were positively correlated, and bore close correlation with DAI, colonoscopic and histologic grades and fecal microbial flora. An important mechanism of UC might be that abnormal activation of mucosal immunity by intestinal dysbacteriosis caused dysregulation of TLRS that mediates innate immunity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318894     DOI: 10.1007/s11596-014-1353-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

1.  Toll gates for pathogen selection.

Authors:  R J Ulevitch
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

Review 2.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

4.  Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

Review 5.  Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.

Authors:  R Balfour Sartor
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-07

6.  Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients.

Authors:  Kaori Fuse; Kyoko Katakura; Natsumi Sakamoto; Hiromasa Ohira
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

7.  Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.

Authors:  E Cario; D K Podolsky
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 8.  Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

Authors:  Maria T Abreu
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

9.  MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells.

Authors:  Christelle Lenoir; Catherine Sapin; Alexis H Broquet; Anne-Marie Jouniaux; Sabine Bardin; Isabelle Gasnereau; Ginette Thomas; Philippe Seksik; Germain Trugnan; Joëlle Masliah; Maria Bachelet
Journal:  Life Sci       Date:  2007-12-17       Impact factor: 5.037

10.  Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Authors:  Fausto Sánchez-Muñoz; Gabriela Fonseca-Camarillo; Marco A Villeda-Ramírez; Elizabeth Miranda-Pérez; Edgar J Mendivil; Rafael Barreto-Zúñiga; Misael Uribe; Rafael Bojalil; Aarón Domínguez-López; Jesús K Yamamoto-Furusho
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

View more
  12 in total

1.  The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis.

Authors:  Sisi Lin; Yongyu Li; Li Shen; Ruiqin Zhang; Lizhi Yang; Min Li; Kun Li; Jakub Fichna
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

2.  Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.

Authors:  Xiao-Yan Zhou; Ming Li; Xia Li; Xin Long; Xiu-Li Zuo; Xiao-Hua Hou; Ying-Zi Cong; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

Review 3.  The Development of the Human Microbiome: Why Moms Matter.

Authors:  Derrick M Chu; Gregory C Valentine; Maxim D Seferovic; Kjersti M Aagaard
Journal:  Gastroenterol Clin North Am       Date:  2019-07-02       Impact factor: 3.806

4.  Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse Colitis.

Authors:  Wei-Lian Bao; Qibiao Wu; Bin Hu; Dongdong Sun; Shengnan Zhao; Xiaoyan Shen; Haibo Cheng; Weixing Shen
Journal:  Int J Nanomedicine       Date:  2021-01-13

5.  Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation.

Authors:  Yoshiyuki Mishima; Shunji Ishihara; Akihiko Oka; Nobuhiko Fukuba; Naoki Oshima; Hiroki Sonoyama; Noritsugu Yamashita; Yasumasa Tada; Ryusaku Kusunoki; Ichiro Moriyama; Takafumi Yuki; Kousaku Kawashima; Yoshikazu Kinoshita
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

Review 6.  Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis.

Authors:  Chunyan Wang; Xudong Tang; Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-12       Impact factor: 2.629

7.  Mesenteric Lymphatic Alterations Observed During DSS Induced Intestinal Inflammation Are Driven in a TLR4-PAMP/DAMP Discriminative Manner.

Authors:  Matthew Stephens; Shan Liao; Pierre-Yves von der Weid
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

8.  Diverse Profiles of Toll-Like Receptors 2, 4, 7, and 9 mRNA in Peripheral Blood and Biopsy Specimens of Patients with Celiac Disease.

Authors:  Haniye Ghasiyari; Mohammad Rostami-Nejad; Davar Amani; Kamran Rostami; Mohamad Amin Pourhoseingholi; Hamid Asadzadeh-Aghdaei; Mohammad Reza Zali
Journal:  J Immunol Res       Date:  2018-07-02       Impact factor: 4.818

9.  Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation.

Authors:  Jia-Dong Zheng; Yan He; Heng-Yuan Yu; Yuan-Li Liu; Yi-Xuan Ge; Xue-Ting Li; Xue Li; Yan Wang; Meng-Ru Guo; Yi-Lin Qu; Xiao-Fa Qin; Ming-Shan Jiang; Xiu-Hong Wang
Journal:  World J Gastroenterol       Date:  2019-04-21       Impact factor: 5.742

Review 10.  TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.

Authors:  Jie Guo; Mengfan Liao; Jun Wang
Journal:  Cell Commun Signal       Date:  2021-09-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.